This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised for Breakouts

Sarepta Therapeutics

Another biotechnology player that's starting to trend within range of triggering a big breakout trade is Sarepta Therapeutics ( SRPT), which discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen. This stock has been under attack by the bears so far in 2013, with shares off sharply by 39%

>>Profit From 5 Trades Warren Buffett Made

If you take a look at the chart for Sarepta Therapeutics, you'll notice that this stock recently gapped down sharply from $37.80 to under $12 a share with heavy downside volume. Following that gap down, shares of SRPT have started to rebound and uptrend from $12.12 to its intraday high on Friday of $15.88 a share. That move is quickly pushing shares of SRPT within range of triggering a big breakout trade above its gap down day high.

Traders should now look for long-biased trades in SRPT if it manages to break out above Friday's high of $15.88 to its gap down day high at $16.70 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 2.82 million shares. If that breakout hits soon, then SRPT will set up to re-fill some of its previous gap down zone that started at $37.80 a share. Some possible upside targets if SRPT gets into that gap with volume are $20 to $25 a share.

Traders can look to buy SRPT off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $14.50 a share. One could also buy SRPT off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
GTIV $19.19 -1.18%
RNA $18.65 0.00%
CCXI $2.04 0.00%
SRPT $17.22 0.00%
TRMR $1.95 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs